PubMed Health⌕ Search

Biomedical subjects

M Maus

Publications and source records attributed to M Maus.

42 records · Page 3Linked to original sources

Pretreatment of mouse striatal neurons in primary culture with 17 beta-estradiol enhances the pertussis toxin-catalyzed ADP-ribosylation of G alpha o,i protein subunits.

Pretreatment of striatal neurons from mouse embryos in primary culture with 17 beta-estradiol (10(-9) M, 24 h) enhanced the ADP-ribosylation of G alpha o,i proteins catalyzed by pertussis toxin (PTX). As estimated by quantitative ADP-ribosylation of G alpha s with cholera toxin and immunoblot experiments using anti-G alpha o and anti-G beta sera, 17 beta-estradiol pretreatment did not modify the levels of the major GTP-binding protein (G protein) constituent subunits G alpha s, G alpha o, and G beta. Thus, 17 beta-estradiol should induce a qualitative modification of these G proteins, perhaps by stabilizing the association of the heterotrimers G alpha o,i beta gamma, which are the targets of PTX. Such a hypothesis is in agreement with observations indicating that 17 beta-estradiol both suppressed the D2 dopamine- and opiate receptor-induced inhibitions of adenylate cyclase activity and enhanced the positive coupling between biogenic amine receptors (D1 dopamine, beta-adrenergic, and A2 adenosine) and adenylate cyclase. In addition, PTX pretreatment, which is known to uncouple receptors associated with Go,i proteins and thus to impair the dissociation of the heterotrimers G alpha o,i beta gamma, mimicks the effects of the steroid on the responses of adenylate cyclase to inhibitory and stimulatory agonists. Finally, the chemical specificity of the steroids was the same in the ADP-ribosylation as in the adenylate cyclase experiments: Testosterone (10(-9) M) mimicked the effects of 17 beta-estradiol, whereas 17 alpha-estradiol, progesterone, and dexamethasone did not.(ABSTRACT TRUNCATED AT 250 WORDS)

2-Chloroadenosine↗

Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells.

Primary cultures of anterior pituitary cells from female rats and of mouse embryonic striatal neurons were used to study the effects of 17 beta-estradiol on D1- and D2-dopamine (DA)-sensitive adenylate cyclase. 17 beta-Estradiol pretreatment (10(-9) M, 72 h) suppressed the D2-DA-induced inhibition of adenylate cyclase activity in anterior pituitary cells. The steroid (10(-9) M, 24 h) also blocked the D2-DA-evoked response in striatal neurons whereas it enhanced by twofold the D1-DA-induced stimulation of the enzyme activity in these neurons. All these effects of the steroid were dose dependent and specific, as neither 17 alpha-estradiol, dexamethasone, nor progesterone used at the same concentration (10(-9) M) was effective. Furthermore, the modulation of DA-sensitive adenylate cyclases by the steroid required long-term exposure of living cells to 17 beta-estradiol since neither 17 beta-estradiol pretreatment for 4 h nor its addition to broken cells directly into the adenylate cyclase assay induced any alteration in the DA-sensitive adenylate cyclase activity. These results are in agreement with a genomic effect of the steroid. Using both anterior pituitary cells and striatal neurons in culture, 17 beta-estradiol affected neither the total number of DA (D1 and D2) receptors nor the estimated number of adenylate cyclase catalytic units. Therefore, it is suggested that the steroid modifies the coupling process by a mechanism that still has to be elucidated. These results demonstrate an effect of 17 beta-estradiol on DA target cells in both systems.(ABSTRACT TRUNCATED AT 250 WORDS)

Adenylyl Cyclases↗

Alternative method for sulcus fixation of posterior chamber lenses in the absence of capsular support.

The realization that posterior chamber intraocular lenses have many advantages over anterior chamber ones has induced many practitioners to try methods of fixating the lenses in the ciliary sulcus when there is inadequate capsular support. Most of these methods require the use of sutures to anchor the lens to the sclera or the iris. We describe a modification of these techniques which allows the surgeon to place a stiff all-polymethylmethacrylate (PMMA) lens in the sulcus in a way that makes it unnecessary to anchor the lens, although a safety suture may be placed through the scleral lip. We believe this modification makes sulcus fixation simpler to perform and possibly safer for the patient. We have used this technique in six patients with good results.

Aged↗